Takeda to buy U.S. cancer drug maker ARIAD Pharmaceuticals

File photo taken in October 2010 shows the Tokyo headquarters of Takeda Pharmaceutical Co. The firm said on Jan. 9, 2017, that it will buy Massachusetts-based ARIAD Pharmaceuticals Inc. in a deal valued at $5.2 billion to expand its cancer treatment business. (Kyodo) ==Kyodo

• Product Code
• ILEA000051982

• Registered date
• 2017/1/10 11:13:21

• Credit
• Kyodo / Kyodo News Images

• Media source
• 2017 Kyodo News

• Media size
• 2896 × 2320 pixel

• Resolution
• 240 dpi

• Deployment size
• 1.29(MB)*

• Special instruction

*File size when opened in Photoshop, etc.